{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:17:45Z","timestamp":1780571865107,"version":"3.54.1"},"reference-count":14,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.3892\/mmr.2016.5354","type":"journal-article","created":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T07:12:44Z","timestamp":1464765164000},"page":"1275-1282","source":"Crossref","is-referenced-by-count":8,"title":["Hydroxychloroquine protects melanocytes from autoantibody-induced injury by reducing the binding of antigen-antibody complexes"],"prefix":"10.3892","volume":"14","author":[{"given":"Dong-Guang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Zhi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Qi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,6,1]]},"reference":[{"key":"key20180108030200_b1-mmr-14-02-1275","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/138920010791526105","article-title":"Vitiligo: Pathogenetic hypotheses and targets for current therapies","volume":"11","author":"Guerra","year":"2010","journal-title":"Curr Drug Metab"},{"key":"key20180108030200_b2-mmr-14-02-1275","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/00128071-200102030-00006","article-title":"Vitiligo: Pathogenesis and treatment","volume":"2","author":"Njoo","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"key20180108030200_b3-mmr-14-02-1275","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mehy.2009.08.008","article-title":"The double strike hypothesis of the vitiligo pathomechanism: New approaches to vitiligo and melanoma","volume":"74","author":"Michelsen","year":"2010","journal-title":"Med Hypotheses"},{"issue":"Suppl 1","key":"key20180108030200_b4-mmr-14-02-1275","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1177\/096120339600500104","article-title":"Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases","volume":"5","author":"Furst","year":"1996","journal-title":"Lupus"},{"key":"key20180108030200_b5-mmr-14-02-1275","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","article-title":"The definition and assessment of vitiligo: A consensus report of the Vitiligo European Task Force","volume":"20","author":"Ta\u00efeb","year":"2007","journal-title":"Pigment Cell Res"},{"key":"key20180108030200_b6-mmr-14-02-1275","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1346-8138.2006.00059.x","article-title":"A modified method for purifying amelanotic melanocytes from human hair follicles","volume":"33","author":"Ma","year":"2006","journal-title":"J Dermatol"},{"key":"key20180108030200_b7-mmr-14-02-1275","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/archderm.1995.01690150078015","article-title":"Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells","volume":"131","author":"Cui","year":"1995","journal-title":"Arch Dermatol"},{"key":"key20180108030200_b8-mmr-14-02-1275","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/1523-1747.ep12476728","article-title":"Coexistence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo","volume":"100","author":"Yu","year":"1993","journal-title":"J Invest Dermatol"},{"key":"key20180108030200_b9-mmr-14-02-1275","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jaut.2007.07.012","article-title":"Apoptosis of melanocytes in vitiligo results from antibody penetration","volume":"29","author":"Ruiz-Arg\u00fcelles","year":"2007","journal-title":"J Autoimmun"},{"issue":"2 Suppl 1","key":"key20180108030200_b10-mmr-14-02-1275","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/S0049-0172(10)80012-5","article-title":"Mechanism of action of hydroxychloroquine as an anti-rheumatic drug","volume":"23","author":"Fox","year":"1993","journal-title":"Semin Arthritis Rheum"},{"key":"key20180108030200_b11-mmr-14-02-1275","first-page":"55","article-title":"Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells","volume":"24","author":"van den Borne","year":"1997","journal-title":"J Rheumatol"},{"key":"key20180108030200_b12-mmr-14-02-1275","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood-2008-03-144204","article-title":"Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers","volume":"112","author":"Rand","year":"2008","journal-title":"Blood"},{"key":"key20180108030200_b13-mmr-14-02-1275","first-page":"145","article-title":"The inhibition of antigen-antibody reactions by chloroquine and its mechanism of action","volume":"146","author":"Holtz","year":"1973","journal-title":"Z Immunitatsforsch Exp Klin Immunol"},{"key":"key20180108030200_b14-mmr-14-02-1275","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/ard.2006.067835","article-title":"Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus","volume":"66","author":"Costedoat-Chalumeau","year":"2007","journal-title":"Ann Rheum Dis"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2016.5354\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T05:20:05Z","timestamp":1515388805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2016.5354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,1]]},"references-count":14,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,6,1]]},"published-print":{"date-parts":[[2016,8]]}},"alternative-id":["10.3892\/mmr.2016.5354"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2016.5354","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,1]]}}}